Texas House Bill HB272

Texas 2009 - 81st Regular

• Filed: 11/17/08

Caption

Relating to disease control programs to reduce the risk of certain communicable diseases.

Impact

The legislation amends the Health and Safety Code by adding a new subchapter that specifically outlines the operations and regulations surrounding disease control programs. Notably, the bill permits local health authorities to charge a fee for needle and syringe exchanges, which must not exceed 150% of the actual cost, thus introducing a potential revenue source for public health initiatives. Additionally, it mandates that program operators report on the effectiveness of their initiatives, thereby ensuring accountability and transparency in the handling of public funds and health strategies.

Summary

House Bill 272 addresses the establishment of disease control programs aimed at reducing the risk of certain communicable diseases, particularly HIV, hepatitis B, and hepatitis C. The bill allows local health authorities or contracted organizations to set up programs that include the anonymous exchange of used hypodermic needles and syringes for new ones, health education in multiple languages, and assistance in accessing health-related services. The legislation is intended to improve public health outcomes through preventive measures against the spread of infectious diseases.

Contention

There are significant implications related to public safety and health concerns surrounding the implementation of these programs. Proponents argue that needle exchange programs can effectively reduce the transmission rates of communicable diseases and provide crucial healthcare services to high-risk populations. However, opponents may challenge the affordability of participation fees, the safety of such exchanges, and the potential for increased drug use in communities. As with similar measures, discussions around appropriate funding sources and community education efforts will be vital to successful implementation.